Concepedia

Publication | Open Access

Circulating Fibroblast Growth Factor 21 Levels Predict Progressive Kidney Disease in Subjects With Type 2 Diabetes and Normoalbuminuria

DOIFull Paper Access

83

Citations

25

References

2015

Year

Chi‐Ho Lee, E. Y. L. Hui, Yu Cho Woo, CK Yeung, Wing Chow, Michele Mae Ann Yuen, Carol Ho-Yan Fong, A Xu, Karen S.L. Lam
The Journal of Clinical Endocrinology & Metabolism

Abstract

Elevated serum FGF21 levels may be a useful biomarker for predicting kidney disease progression, especially in the early stages of diabetic nephropathy.

References

YearCitations

Page 1